TotalMarketCap

Syndax Pharmaceuticals

SNDXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$842.750 M

$9.37 -10.38%

Close of 6 Nov 2026

As of 6 Nov 2026, Syndax Pharmaceuticals (SNDX) has a market capitalization of $842.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$172.4M

#2322 by revenue

Earnings

-$285.4M

Loss-making

Shares outstanding

89,297,086

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #154City TherapeuticsCTY$855.1M
  2. #155Rigel PharmaceuticalsRIGL$848.1M
  3. #156Syndax PharmaceuticalsSNDX$842.8M
  4. #157Corvus PharmaceuticalsCRVS$821.0M
  5. #158Aktis OncologyAKTS$820.9M

What if Syndax Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$313,780.18

Per share 33,506× higher

Bitcoin $1.53T

$16,978.10

Per share 1,813× higher

Apple $5.02T

$55,737.52

Per share 5,952× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Syndax Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.